You are here

Wegovy

Adherence to weight-loss drugs is far higher with Wegovy than older medicines

Adherence to weight-loss drugs is far higher with Wegovy than older medicines

Reuters

patient adherence

Flag link:

As Ozempic cases mount, consumer lawyers push to consolidate lawsuits

As Ozempic cases mount, consumer lawyers push to consolidate lawsuits

Reuters

Flag link:

Maker of Wegovy, Ozempic showers money on U.S. obesity doctors

Maker of Wegovy, Ozempic showers money on U.S. obesity doctors

Reuters

Flag link:

US obesity docs expect Lilly weight-loss drug to show similar heart benefit as Wegovy

US obesity docs expect Lilly weight-loss drug to show similar heart benefit as Wegovy

Reuters

Flag link:

Biohaven hopes to muscle in on Ozempic with a different type of weight loss drug

Biohaven hopes to muscle in on Ozempic with a different type of weight loss drug

BioPharma Dive

Flag link:

The Next Generation of Weight Loss Drugs is Rapidly Approaching

The Next Generation of Weight Loss Drugs is Rapidly Approaching

BioSpace

Flag link:

Novo Nordisk offers staff free Wegovy

Novo Nordisk offers staff free Wegovy

Beckers Hospital Review

employee benefits

Flag link:

Novo Nordisk fights back at Lilly with Wegovy combo trial against Zepbound in obesity

Novo Nordisk fights back at Lilly with Wegovy combo trial against Zepbound in obesity

https://bit.ly/49zNkYL

clinical trials

Flag link:

Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss

Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss

Fierce Pharma

cardiovascular disease

clinical trials

Flag link:

Wegovy cuts risk of heart attacks in milestone cardiovascular trial

Wegovy cuts risk of heart attacks in milestone cardiovascular trial

Stat

clinical trials

cardiovascular disease

Flag link:

Lilly’s Zepbound vs. Novo’s Wegovy: The Weight-Loss Drug Race Has Officially Started

Lilly’s Zepbound vs. Novo’s Wegovy: The Weight-Loss Drug Race Has Officially Started

Motley Fool

Flag link:

Senator floats new models to manage costs of weight loss drugs like Ozempic

Senator floats new models to manage costs of weight loss drugs like Ozempic

Stat

Flag link:

People Are Paying $25 for Wegovy, and It's Going to Keep Making Novo Nordisk Billions

People Are Paying $25 for Wegovy, and It's Going to Keep Making Novo Nordisk Billions

Motley Fool

Flag link:

Novo, Lilly Weight-Loss Drug Juggernaut Has Nowhere to Go But Up

Novo, Lilly Weight-Loss Drug Juggernaut Has Nowhere to Go But Up

BioSpace

Flag link:

Novo Nordisk is concluding research on Wegovy’s impact on osteoarthritis

Novo Nordisk is concluding research on Wegovy’s impact on osteoarthritis

Stat

Flag link:

Pfizer’s twice daily pill for obesity hopes to rival Wegovy and Mounjaro

Pfizer’s twice daily pill for obesity hopes to rival Wegovy and Mounjaro

Stat

Flag link:

Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.

Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.

Motley Fool

Flag link:

High-flying Novo Nordisk once again dials up its 2023 sales and profit expectations

High-flying Novo Nordisk once again dials up its 2023 sales and profit expectations

Fierce Pharma

Flag link:

Far More Employers Could Cover Weight Loss Drugs Like Wegovy Next Year—Here’s What That Means For Costs

Far More Employers Could Cover Weight Loss Drugs Like Wegovy Next Year—Here’s What That Means For Costs

Forbes

Flag link:

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

CP Wire/Businesswire

Flag link:

Pages